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Abstract
Introduction: Human T-cell lymphotropic virus type 1 (HTLV-1) infection is intractable and endemic in many countries.
Although a few individuals have severe symptoms, most patients remain asymptomatic throughout their lives and their
infections may be unknown to many health professionals. HTLV-1 can be considered a neglected public health problem and
there are not many studies specifically on patients’ needs and emotional experiences.
Objective: To better understand how women and men living with HTLV-1 experience the disease and what issues exist in
their healthcare processes.
Methods: A qualitative study using participant observation and life story interview methods was conducted with 13
symptomatic and asymptomatic patients, at the outpatient clinic of the Emilio Ribas Infectious Diseases Institute, in Sao
Paulo, Brazil.
Results and Discussion: The interviewees stated that HTLV-1 is a largely unknown infection to society and health
professionals. Counseling is rare, but when it occurs, focuses on the low probability of developing HTLV-1 related diseases
without adequately addressing the risk of infection transmission or reproductive decisions. The diagnosis of HTLV-1 can
remain a stigmatized secret as patients deny their situations. As a consequence, the disease remains invisible and there are
potentially negative implications for patient self-care and the identification of infected relatives. This perception seems to
be shared by some health professionals who do not appear to understand the importance of preventing new infections.
Conclusions: Patients and medical staff referred that the main focus was the illness risk, but not the identification of
infected relatives to prevent new infections. This biomedical model of care makes prevention difficult, contributes to the
lack of care in public health for HTLV-1, and further perpetuates the infection among populations. Thus, HTLV-1 patients
experience an ‘‘invisibility’’ of their complex demands and feel that their rights as citizens are ignored.
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Introduction
The human T-cell lymphotropic type 1 (HTLV-1) [1] infection
causesa life-longinfection for infected subjects. HTLV-1 is endemic
in various parts of the world, including Japan and countries in
Africa, the Caribbean and South America [2]. It has been estimated
that over 10 million individuals are infected with HTLV-1 [3], but
mostinfectedpersonsareasymptomaticandprobablyarenotaware
of their serological status. In addition, asymptomatic individuals
may still infect sexual partners or offspring.
The most common diseases associated with HTLV-1 infection
are adult T-cell leukemia/lymphoma (ATL) and HTLV-1-
associated myelopathy/tropical spastic paraparesis (HAM/TSP)
[4]. No accurate case statistics exist for ATL or HAM/TSP
because these diseases are not reportable by the World Health
Organization (WHO). Despite several publication reviews on
pathogenesis or molecular biology of HTLV-1 [5,6], few studies
have addressed treatments for HTLV-1 or the psychological issues
related to having the disease. Therefore, HTLV-1 infection is
considered, and was recently reported, as a neglected disease [7].
Brazil has received worldwide recognition for the country’s
public health policies, especially with respect to how the nation has
addressed the pandemic of HIV/AIDS [8]. Such success against
HIV/AIDS was possible only because Brazil’s constitution
recognizes and guarantees healthcare as a right of every citizen
and the country’s public health ministry provides a multidisciplin-
ary prevention program and free medication for HIV/AIDS. [8].
However, such public health policies have not been applied to
HTLV-1 infection, which is not even listed as an infectious disease
that should be addressed by public health action. Thus, HIV/
AIDS may overshadow the problem of HTLV-1 in Brazil, and
consequently, HTLV-1 has become essentially unknown to most
of health professionals and should be considered a public health
problem in Brazil [9].
Few HTLV-1 epidemiological studies have been conducted in
the general population, but the average prevalence of HTLV-1/2
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based on study population showed prevalence of 1.7% in
Salvador, with 40000 individuals are estimated to be infected by
HTLV-1 [11]. The highest prevalence of HTLV-1 has been
recorded in Sa ˜o Luı ´s city in Maranha ˜o, with 10.0/1000 and
Salvador in Bahia with 9.4/1000 [11]. However, other cities may
present lower prevalence despite geographical proximity, which
indicates heterogeneous distribution and cluster pattern [12].
In 1993, it was recommended by ministry of health the
mandatory tests for hepatitis C and HTLV-1/2 in blood banks.
In 2002, Brazil also instituted a policy which provided free testing
of HIV/AIDS and syphilis during prenatal care visits as an
approach to preventing mother-to-child-transmission (PMTCT).
However, the same policy was not provided for HTLV-1
infection and the Brazilian Ministry of Health only published
the Guide Recommendations on HTLV Management in 2003,
without update [13].
From a public health perspective, prevention of HTLV-1 is
crucial, especially because HTLV-1 is a life-long infection and is
currently incurable and untreatable. The health field recognizes
that disease prevention requires strategies beyond strictly medical
approaches. Thus, the aim of this study was to identify perceptions
of HTLV-1 by women and men living with this infection, and to
better understand their families, subjective issues, needs and how
they cope with health care.
Materials and Methods
The present study was conducted by using participant
observation methods [14] in the HTLV outpatient clinic at the
Emı ´lio Ribas Infectious Diseases Institute in Sa ˜o Paulo, Brazil
from June 2006 to April 2008. This is centenary national public
referral hospital specializing in the diagnosis and treatment of
individuals with infectious diseases.
Using a thematic script and in parallel an in-depth interviews
with 13 individuals (11 women and two men) diagnosed with
HTLV-1 infection and without co-infections (see Table 1).
Subjects were selected and interviewed during the regular visit
to the HTLV clinic. This convenience sample tried to cover the
most part of situations such as gender, presence of symptoms,
serological couple status and so on [14].The questions of the
thematic script were about the subjects history of life, their
knowledge and experiences related to the HTLV-1 infection,
related diseases and family perception of HTLV-1 serological
status disclosure.
Data were analyzed by using life narratives from each subject
and constructed content categories from these narratives [15]. The
reported names of participants are fictitious in order preserve their
privacy and identities.
The study was approved by the Ethical Research Board
Committee - CAPPesq (n. 297/06) and the Emı ´lio Ribas Institute
of Infectious Diseases Ethical Committee (n. 34/06). The
volunteers signed an informed consent form that faithfully follows
the resolution of the national Ministry of Health (CNS 196/96)
and the Declaration of Helsinki.
Author Summary
Human T-cell lymphotropic virus type 1 (HTLV-1) infection
is commonly confounded with Human Immunodeficiency
Virus (HIV) infection and it is unknown to many health
professionals. It is endemic in many countries and there is
no effective treatment available. Although a few individ-
uals have severe symptoms, most patients remain asymp-
tomatic throughout their lives. Further, HTLV-1 is consid-
ered a neglected public health problem and limited
studies cover specific patients’ needs and emotional
experiences. To better understand how women and men
living with HTLV-1 experience the disease and what issues
exist in their healthcare processes, we conducted a
qualitative study of both symptomatic and asymptomatic
patients at an outpatient clinic at the Emı ´lio Ribas
Infectious Diseases Institute in Sa ˜o Paulo, Brazil. We found
that the main focus of health staff was on illness risk, but
not identifying infected relatives and preventing new
infections. This point of view, ultimately neglected
patients’ complex demands, and overshadows the pre-
vention of new infections and contributes to the lack of
care in public health for HTLV-1 infected subjects.
Furthermore, this perpetuates the infection among these
populations and the patients experience an ‘‘invisibility’’ of
their specific needs, such as reproductive rights and feel
that their rights as citizens are ignored.
Table 1. Socio-demographic characteristics and HTLV-1 infection data for interviewed patients.
Name Age (years) Marital status Education (years) Symptomatic Children Relatives tested Modes of transmission
Lidia 34 single 8 yes none no MTCT
Ana 27 married 11 yes 1 no MTCT
Ange ´lica 26 divorced 5 yes 3 no blood transfusion
Alba 27 married 6 yes none no MTCT
Marta 31 married 16 no none no unknown
Carolina 61 widower 11 no 2 no unknown
Silvia 42 married 11 no 3 no unknown
Alice 23 married 11 no none no MTCT
Fabiana 27 married 16 no none no unknown
Maria 27 married 11 no pregnant yes sex
Maria Rita 27 married 11 no 1 pregnant no unknown
Victor 47 divorced 5 yes 3 no unknown
Walter 33 married 11 yes wife pregnant no MTCT
doi:10.1371/journal.pntd.0001705.t001
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The invisibility as a central category of analysis
While HTLV-1 infection is frequently ‘‘invisible’’ in a literal
way, this article aimed to highlight the disease’s symbolic
invisibility from patients’ perspectives and life experiences, as well
as patients’ relations with healthcare providers.
The view of people with HTLV-1: feeling invisible from
being diagnosed with an ‘‘invisible’’ disease
The HTLV-1 diagnosis is frequently a doubts and fear
moment in primary medical care settings. While recalling their
original diagnosis, subjects reported an initial shock followed by
some feelings of denial (e.g., ‘‘it is not true’’) or hopefulness for a
‘‘cure.’’ In addition, many participants thought that their illness
was HIV infection, which has been similarly reported by
Guiltinan (1998) [16]. This erroneous observation was also found
in some health professionals speeches. Subsequently, this confu-
sion illustrated the lack of knowledge about HTLV-1 among
health professionals and society in general. Furthermore, subjects
reported insecurity and doubts about the abilities of their primary
healthcare providers; however, patients indicated that these
problems were better addressed when they were referred to
specialized care.
Interestingly, many subjects reported that ‘‘it was better not to
know about HTLV’’ and ‘‘not to think about HTLV’’. These
observations indicated the use of denial as a defense mechanism.
Subjects also reported fear of disclosure and that their HTLV-1
diagnoses would be disrupted family relations. Consequently, this
perception leads subjects to hide their HTLV-1 diagnosis from
everyone, as a ‘‘secret.’’ Such difficulties have also been observed
in people living with HIV/AIDS [17], especially as related to
their fears of disease stigma [18]. Subjects noted ‘‘justification[s]’’
for keeping their disease status secret, reasoning that ‘‘family
members are healthy, symptomless and therefore there is no need
worry’’ and they did not want to cause emotional suffering for
relatives. These statements illustrated elements of a singular logic
underlying the desire for HTLV-1 concealment among family
members.
Regarding this ‘‘secret,’’ the thoughts and perceptions between
subjects and health providers seem connected. Subjects and
providers understood the absence of HTLV-1 symptoms as
‘‘normal’’, in consequence HTLV-1 infection remained ‘‘invisible’’
because they are focused on risk of sickness. This observation has
important implications for understanding the lack of diagnosis
among partners and family members.
‘‘Living with HTLV is normal for me. I feel nothing, do not take any
medication. For me, HTLV does not bring any problem, feel anything.
How can I bring my mother to be tested, disturbing everyone?’’ (Silvia,
42 years old, married, asymptomatic, has three children).
‘‘I prefer not to think and not bring my children to be tested. I think it is
better this way. I’m dealing with HTLV. I do not want to mention it.
If I do this, it can mess with my children minds’’. (Victor, 33 years old,
married, symptomatic - HAM/TSP)
Except for Maria, all subjects indicated that someone in their
family circle (i.e., sexual partners, relatives or children) should be
tested for HTLV-1 infection but had not been tested yet. This
situation illustrated how poor HTLV-1 disclosure among family
members has negative consequences. In Maria’s case the lack of
disclosure was the possible cause of her infection, because Maria’s
husband, Walter, was infected by his mother, and hidden his
HTLV-1 infection from her. Her husband, Walter, did not reveal
his diagnosis to his wife because he thought they were both
healthy. Although his wife was pregnant (30 weeks), Walter only
sought medical attention when he began to have symptoms of
HAM/TSP. Only on this time, his health team requested to his
pregnant woman to be tested for HTLV-1 infection.
The symptomatic condition further expanded upon these issues,
as patients experience changes in their daily activities, self-image
and social lives. The progressive disability associated with
symptomatic HTLV-1 infection limited these patients’ lives, as
illustrated by the sentences below.
‘‘After I developed this disease my husband told me that I’m not good for
anything anymore. As much as we do not want to remember this, this
prejudice keeps reminding us of the disease’’ (Angelica, 26 years old,
divorced, HAM/TSP, has three children).
‘‘People already have a bias to get close because I was not walking well.
If you have a problem, they say that you are no different. They say that
you are the same. But it is not true! You have a huge problem because
you have a difficulty to walk. Imagine if you say that you have an
infectious disease’’ (Lidia, 34 year old, single, HAM/TSP, has no
children).
The suffering and mobility limitations constitute ‘‘narcissistic
injuries’’ [19], which is related to the self-steam in deeper
emotional level or in unconscious influence. This situation
generated intense anxiety, defense mechanisms and required
coping strategies among these patients. In this context, it is
understandable that persons living with HTLV-1 had difficulties,
which may explain reluctance to share their experiences with their
family.
Subjects report that their perceptions and experiences changed
when their family members are symptomatic. HTLV-1 becomes
present in subjects’ lives through the symptoms of their family, and
the need to care for these members may trigger additional
emotional coping mechanisms.
In cases where subjects know that they were infected by their
parents, HLTV-1 infection is viewed as a type of ‘‘family heritage’’
that the subject must ‘‘carry for life.’’ This knowledge may be very
painful emotionally, as demonstrated by Alba and Walter:
‘‘I can not accept it. I thought, why my story is so painful? HTLV is
one heritage! I kept myself a virgin for my future husband. I did not get
anything financially from my family but I inherited a disease’’ (Alba,
27 yeas old, married, HAM/TSP, has no children).
‘‘HTLV is a painful thing because it’s something we will carry for
life’’. (Walter, 33 years old, married, HAM/TSP).
This lack of disclosure to partners and family on HLTV-1
diagnosis could be explained by poor information regarding
infection transmission; however, the speeches revealed an appro-
priate understanding of transmission modes. On the other hand,
some subjects had doubts how they became infected. These
subjects were not willing to search for this information, which
illustrates their difficulties in dealing with the HLTV-1 diagnoses.
Invisibility among persons living with HTLV-1 may have
meaning, especially because patients have reported feeling
stigmatized and socially disadvantaged (e.g., ‘‘discarded’’ or
‘‘limited’’) since receiving their diagnoses [17]. As patients became
aware of their HTLV-1 infection, they were forced to reorganize
their priorities. Reproductive decisions and sexuality were
especially pronounced, as Alba’s speech illustrated.
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something to no longer generate another discarded person in my family.
Another contaminated one in the family.’’ (Alba, 27 years old, married,
HAM/TSP, has no children, her father also has HAM/TSP).
Health professionals and their healthcare practices from
the subjects’ perspective: hegemonic conceptions and
practices in HTLV-1 prevention
According to subjects, primary health teams are generally
unaware of HTLV-1 and did not investigate or recognize the
health problems associated with the infection and disease. Subjects
reported a poor access to pre- and post-test counseling for HTLV-
1 infection. In fact, an author showed that a person can be tested
and remained without access to specific information and follow up
[16]. Even when subjects had some guidance in counseling, health
professionals focused on low risk of developing symptoms and
failed to emphasize the risk of transmission to partners or to
provide orientation regarding reproductive decisions and mater-
nal-infant transmission risks.
Most interviewers reported they were the only sources of
information about HTLV for the health teams, which created
uncertainty concerning the teams’ medical knowledge. This
finding leads to a paradoxical question on healthcare for HTLV:
how can a doctor inform and treat patients when himself does not
know HTLV? Maria and Maria Rita’s speeches, who were both
pregnant, illustrated this paradox.
‘‘The doctor asked me what HTLV infection is. But I did not know it
either. Even doctors do not know what it is, can I imagine? They said ‘I
cannot say anything. I will first study and then I will see what I have to
do’’’ (Maria, 27 years old, married, asymptomatic, pregnant, one child
who is eight years old).
The obstetrician who provided prenatal care explained the following to
Maria Rita: ‘‘You have a virus like AIDS. I do not know if this disease
can be transmitted to the baby. I do not know anything about this
virus’’. Another medical staff member, during an ultrasound exam, told
her: ‘‘If the virus has infected the baby, apparently it did not affect
anything. But I do not know anything about this virus’’.
The ‘‘invisibility’’ of HTLV-1 infection should not be a problem
for symptomatic patients such as HAM/TSP and ATL cases.
However, this study revealed that symptomatic patients had to
make ‘‘pilgrimages’’ to several specialists as they searched for a
diagnosis. In fact, HAM/TSP patients experienced an average of
eight years seeking a diagnosis [20], extending up to 11 years in
some cases [21]. Being symptomatic, or considered a ‘‘patient,’’
should generate the search to identify the cause of symptoms. For
HAM/TSP diagnosis, the HCP must have the knowledge and
make the differential diagnosis, which firstly requires HTLV-1
serology. Unfortunately, HTLV-1 serology is not always available,
even in institutions which are specialized in treating mobility
problems [21].
Interviewers and medical staff were concerned on the risk of
disease development, which is considered ‘‘low’’ for both parties.
Healthcare providers and HTLV-infected subjects frequently do
not realize that asymptomatic individuals may transmit the virus to
partners or offspring. Consequently, preventive processes may
become ineffective.
In conclusion, there appeared to be an underlying logic for the
‘‘invisibility’’ in people living with HTLV-1. Even when individ-
uals had access to necessary information regarding the disease,
they frequently denied the situation. In consequence, there were
implications for self-care and understanding the need for testing
family members for HTLV-1 infection.
As people living with HTLV-1 struggle to cope with this health
problem, it is possible to observe that these difficulties were
logically articulated through the hegemonic healthcare approach.
This hegemonic conception of health care is referred to major
paradigm in health focused at the biomedical approach. Nowa-
days, it has been questioned by the researchers at the public health
field to contrast this model to the bio-psych-social model which
aims the health care in the entire complexity. The biomedical
perspective does not encourage prevention activities and health
promotion [22]. The current hegemonic context, a true ‘‘poor-
care’’ exists toward people living with HTLV-1, further contrib-
uting to the perpetuation of this neglected disease by society in
endemic areas.
Beyond the ‘‘invisibility’’ of HTLV-1, there is an ‘‘invisibility’’
of the subjects living with the infection or disease, their individual
difficulties and idiosyncrasies [23], and their rights as citizens. In
order to bring HTLV-1 from ‘‘invisibility’’ to ‘‘visibility,’’ the
paradigm of standard healthcare should focus on effective
preventive practices, which may consider patients’ complex
demands. Reports from subjects also indicated the need for
studies on sexuality and reproductive decisions among people
living with HTLV-1 infection, as these issues had been shown to
directly influence prevention efforts.
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